Bard Recovery ® IVC filters were first approved by the FDA in 2002. They are umbrella-like medical devices implanted in the pulmonary artery to prevent blood clots from reaching the lungs.
Individuals with thromboembolic diseases or people at risk of pulmonary embolism (PE) or deep vein thrombosis (DVT) and unable to take an anticoagulant are often advised to undergo IVC filter implantation in certain situations; for example:
- Before undergoing major surgery
- Trauma recovery (e.g., following a car wreck, amputation, burn injury, internal bleeding or head injury)
- Recent bleed into the brain
- Emergency treatment following massive pulmonary embolism
- Many other conditions that put patients at high risk of major bleeding
These devices involve a number of risk factors, however, and Bard Recovery ® filters in particular have been indicated to have a high failure rate by a number of studies.
If you or a loved one has experienced health problems involving an IVC filter, it is critical that you speak with an experienced defective medical device lawyer as soon as possible. You have legal options for financial recovery that can help you find relief from medical debt and get your life back on track.
At Lee Murphy Law Firm, we are currently reviewing potential Bard Recovery ® IVC filter lawsuits and other IVC filter lawsuits on behalf of patients throughout the U.S. Our attorneys have extensive experience pursuing cases against negligent medical device manufacturers. We can provide you with personalized service and fight for your maximum compensation.
Bard Recovery ® IVC Filters | A High Rate Of Failure
Bard IVC filters have had persistent problems since their introduction to the market. Devices may fracture, causing particles to migrate to the heart or perforation of other bodily organs and tissue, which may lead to severe medical complications. A number of published studies have placed the failure rate of Bard Recovery ®IVC filters between 21 and 31.7 percent:
- A 2005 study by the New England Society of Vascular Surgery found a 31.7 percent fracture rate after examining adverse event reports that were filed with the FDA.
- A 2008 study published in the Journal of Vascular and Interventional Radiology found a 21 percent failure rate among patients in the study.
- A 2010 study published in the Archives of Internal Medicine found a 25 percent rate of complications among patients in the study.
The company attempted to reduce the rate of failure with the advent of the Bard G2 ® filter in 2005, but risk factors are still present.
We hold medical device manufacturers accountable for defective product design, manufacture, marketing and distribution. Call us today to discuss your individual legal options specific to your unique case.
Our IVC filter complications lawyers represent clients throughout the United States, including Texas, New York and California.